Veran is a privately held medical device company headquartered in St. Louis, MO. The companys main focus is assisting physicians in the early diagnosis and treatment of lung cancer. In the United States, lung cancer kills more people each year than breast, prostate, pancreatic and colon cancers combined. Veran has developed and commercialized an FDA cleared, next generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System which features SPiN Perca proprietary technology that allows physicians to seamlessly transition from navigated bronchoscopy to navigated TTNA in a single procedure. Verans breakthrough technology has been adopted by leading cancer centers throughout the United States.